Furthermore, our results indicate that Pak1 and CaMKII expression is correlated in human breast cancer specimens, and our analysis of the METABRIC study showed significantly worse overall survival in breast cancer patients with co-expression of Pak1 and CaMKII. Here, CAMK2G is linked to breast cancer.